Anxiety and Medical Cannabis UK — Patient Guide

Anxiety Disorders in the UK

Anxiety disorders are the most common mental health conditions in the UK, affecting an estimated 8.2 million people — approximately one in eight adults. The umbrella term encompasses generalised anxiety disorder (GAD), panic disorder, social anxiety disorder, specific phobias, and separation anxiety. Anxiety disorders frequently co-occur with depression, PTSD, and chronic pain, creating complex clinical presentations that are difficult to treat with a single therapeutic approach.

Standard treatments include psychological therapies (CBT, which NICE rates as most effective), pharmacotherapy (SSRIs, SNRIs, and in acute settings, benzodiazepines), and lifestyle interventions. Despite these options, a significant proportion of patients — estimated at 30–40% — have treatment-resistant or partially responsive anxiety, and many experience intolerable side effects from antidepressants. Medical cannabis, particularly high-CBD preparations, is attracting growing interest as an adjunctive or alternative option.

How Cannabis Affects Anxiety — The Dose-Dependent Effect

The relationship between cannabis and anxiety is notably dose-dependent and is one of the most important concepts for anxious patients to understand before commencing treatment. Cannabis can both reduce and exacerbate anxiety depending on the preparation, dose, individual susceptibility, and setting:

Low-Dose THC — Anxiolytic

At low doses (2.5–5mg THC), many patients experience relaxation, reduced muscle tension, and diminished anxiety. This effect is mediated via CB1 receptor activation in the amygdala, which reduces the "threat salience" of anxiety-provoking stimuli, similar to the mechanism of action of benzodiazepines but through a completely different receptor system and without significant respiratory depression or comparable physical dependence.

High-Dose THC — Anxiogenic

At higher doses (10mg+ THC), particularly in cannabis-naive patients or those with pre-existing anxiety, THC can paradoxically increase anxiety, paranoia, and panic. This is believed to result from overstimulation of CB1 receptors in the prefrontal cortex, leading to impaired executive control over fear responses. It is one of the most common adverse effects reported in medical cannabis trials and is the key reason why anxiety treatment should always begin with very low THC doses under clinical supervision.

CBD vs THC for Anxiety

CBD is the preferred cannabinoid for anxiety disorders in the UK, and there is a substantial clinical evidence base supporting its use:

• A landmark 2019 retrospective study published in The Permanente Journal found that CBD reduced anxiety scores in 79.2% of patients within the first month of treatment.
• Multiple double-blind RCTs have shown that CBD (300–600mg acute dose) significantly reduces anxiety in both clinical populations and healthy volunteers exposed to stress paradigms (e.g., public speaking test).
• CBD's anxiolytic effects appear to be mediated via 5-HT1A serotonin receptor partial agonism — the same receptor targeted by buspirone — as well as through FAAH inhibition (increasing endogenous anandamide levels).

For most anxiety patients, a high-CBD prescription (20:1 CBD:THC or greater) is the appropriate starting point, with THC carefully introduced only if clinical response is inadequate.

High-CBD Strains Recommended for Anxiety

The following strains are most commonly prescribed for anxiety disorders in the UK. Browse the full profiles in our strain database:

• ACDC — 20:1 CBD:THC ratio; mild, non-intoxicating, suitable for daytime anxiety management
• Cannatonic — approximately 1:1 CBD:THC; gentle relaxation without strong sedation
• Harlequin — 5:2 CBD:THC; reliably uplifting with minimal psychoactivity
• Charlotte's Web derivatives — very high CBD, trace THC; primarily used in oil form for daily supplementation

High-CBD preparations are also available as pharmaceutical-grade oils, which allow precise titration and are generally preferred over flower for anxiety conditions where dose consistency is paramount.

Clinics Specialising in Anxiety

Most UK cannabis clinics treat anxiety, but some have specific psychiatric expertise. When evaluating clinics, prioritise those with:

• A consultant psychiatrist or clinical psychologist on their team
• Experience with anxiety disorders specifically (not just pain)
• A clear protocol for high-CBD prescribing and THC introduction if needed
• Mental health monitoring as part of the prescription review process

Use our clinic comparison to filter by speciality, and read our guide on how to choose a cannabis clinic. You can also compare costs before committing to a clinic.

Risks of High-THC Preparations

For anxiety patients specifically, the risks of high-THC preparations deserve emphasis:

• Acute anxiety and panic attacks: Most commonly reported adverse effect in cannabis-naive patients; usually resolves as THC is metabolised but can be severely distressing
• Depersonalisation and derealisation: High-THC doses can induce transient dissociative experiences, which are particularly alarming for patients with anxiety disorders
• Dependence: Approximately 9% of cannabis users develop cannabis use disorder; anxiety patients may be at higher risk due to negative reinforcement patterns (using cannabis to relieve anxiety then becoming reliant on it)
• Psychosis risk: Daily high-THC use approximately doubles the risk of psychotic disorder in susceptible individuals; prior history of psychosis or first-degree family member with schizophrenia is a contraindication
• Interaction with SSRIs: Both CBD and THC inhibit CYP2D6 and CYP3A4 enzymes and may alter the plasma levels of commonly co-prescribed antidepressants; prescribers should review the full medication list

Starting Treatment — Practical Steps

For anxiety patients, the recommended pathway is:

1. Book an initial consultation with a specialist cannabis clinic (see clinic list)
2. Disclose full psychiatric history, current medications, and previous cannabis experience
3. Expect to start on a high-CBD oil (20:1 or greater) at a dose of 25–50mg CBD/day
4. Review after 4–6 weeks; THC may be cautiously introduced at 1–2.5mg if response is incomplete
5. Maintain regular follow-up with standardised anxiety scoring (GAD-7) to track progress objectively
6. Do not stop existing prescribed medications without discussing with your GP or psychiatrist

Medical cannabis is most effective for anxiety as part of a broader programme that includes psychological therapy — it is a complement to, not a replacement for, evidence-based treatments like CBT.